{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:50:52Z","timestamp":1791445852754,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jcjo.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T04:02:16Z","timestamp":1507867336000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of herpes zoster ophthalmicus: a systematic review and Canadian cost-comparison"],"prefix":"10.1016","volume":"53","author":[{"given":"Stacy","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monali S.","family":"Malvankar-Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2017.08.005_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.08.005_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bjo.71.5.353","article-title":"Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement","volume":"71","author":"Harding","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9394(68)93869-5","article-title":"Histopathology of herpes zoster ophthalmicus","volume":"65","author":"Naumann","year":"1968","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes zoster eye complications: rates and trends","volume":"88","author":"Yawn","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcjo.2017.08.005_bib5","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2017.08.005_bib6","first-page":"861","article-title":"Post-herpetic neuralgia","volume":"5","author":"Tontodonati","year":"2012","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jcjo.2017.08.005_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1386-6532(03)00125-2","article-title":"Herpes zoster guidelines of the German Dermatological Society","volume":"27","author":"Gross","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00002512-199608020-00004","article-title":"Antiviral therapy of acute herpes zoster in older patients","volume":"8","author":"Herne","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jcjo.2017.08.005_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-4453(83)94041-0","article-title":"The mechanism of action, pharmacokinetics and toxicity of acyclovir\u2014a review","volume":"6","author":"Brigden","year":"1983","journal-title":"J Infect"},{"key":"10.1016\/j.jcjo.2017.08.005_bib10","first-page":"93","article-title":"Oral acyclovir in the treatment of herpes zoster in general practice","volume":"102","author":"Morton","year":"1989","journal-title":"N Z Med J"},{"key":"10.1016\/j.jcjo.2017.08.005_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.293.6561.1529","article-title":"Oral acyclovir in acute herpes zoster","volume":"293","author":"McKendrick","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jcjo.2017.08.005_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.1994.170","article-title":"Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus","volume":"8","author":"Neoh","year":"1994","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2017.08.005_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0161-6420(92)31849-4","article-title":"Oral acyclovir for herpes zoster ophthalmicus","volume":"99","author":"Hoang-Xuan","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.08.005_bib14","first-page":"62","article-title":"Zoster-associated chronic pain: an overview of clinical trials with acyclovir","volume":"80","author":"Crooks","year":"1991","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.jcjo.2017.08.005_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archopht.1990.01070040043027","article-title":"The herpetic eye disease study","volume":"108","author":"Dawson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib17","unstructured":"Ontario Drug Benefit Formulary\/Comparative Drug Index. 2017. Available from: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/formulary42\/edition_42.pdf. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib18","unstructured":"Quebec List of Medications. 2017. Available from: http:\/\/www.ramq.gouv.qc.ca\/SiteCollectionDocuments\/liste_med\/liste_med_cor1_2017_04_01_en.pdf. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib19","unstructured":"Manitoba Drug Interchangeability Formulary. 2017. Available from: http:\/\/www.gov.mb.ca\/health\/mdbif\/docs\/schedule.pdf. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib20","unstructured":"Saskatchewan Ministry of Health Drug Plan. 2017. Available from: http:\/\/formulary.drugplan.ehealthsask.ca\/default.aspx. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib21","unstructured":"Alberta Health Healthcare Insurance. 2017. Available from: https:\/\/idbl.ab.bluecross.ca\/idbl\/search.do. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib22","unstructured":"BC PharmaCare Formulary Search. 2017. Available from: https:\/\/pharmacareformularysearch.gov.bc.ca\/faces\/Search.xhtml. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib23","unstructured":"Nova Scotia Formulary. 2017. Available from: https:\/\/novascotia.ca\/dhw\/pharmacare\/documents\/formulary.pdf. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib24","unstructured":"The Newfoundland and Labrador Interchangeable Drug Products Formulary. 2017. Available from: http:\/\/www.health.gov.nl.ca\/health\/nlpdp\/formularyvol76.pdf. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib25","unstructured":"Yukon Drug Formulary. 2017. Available from: http:\/\/apps.gov.yk.ca\/drugs\/f?p=161:9000:3635077145702816. Accessed July 24, 2017."},{"key":"10.1016\/j.jcjo.2017.08.005_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/bjo.85.5.576","article-title":"Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study","volume":"85","author":"Tyring","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000310447","article-title":"Epidermal growth factor in the topical treatment of herpetic corneal ulcers","volume":"208","author":"Cellini","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jcjo.2017.08.005_bib28","first-page":"729","article-title":"Observation of oral acyclovir combined with sodium hyaluronate and fluorometholone eye drops on the treatment of herpes zoster keratitis","volume":"14","author":"Chen","year":"2014","journal-title":"Int Eye Sci"},{"key":"10.1016\/j.jcjo.2017.08.005_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjo.74.5.283","article-title":"A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis","volume":"74","author":"Porter","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib30","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"10.1016\/j.jcjo.2017.08.005_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/02713689109020376","article-title":"Oral acyclovir in herpes zoster ophthalmicus","volume":"10","author":"Harding","year":"1991","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2017.08.005_bib32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","article-title":"Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus","volume":"107","author":"Colin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.08.005_bib33","first-page":"27","article-title":"Efficacy of famciclovir in the treatment of herpes zoster","volume":"15","author":"Tyring","year":"1996","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2165\/00003495-200059060-00009","article-title":"Valaciclovir: a review of its use in the management of herpes zoster","volume":"59","author":"Ormrod","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jcjo.2017.08.005_bib36","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2165\/00003495-200666180-00016","article-title":"Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes","volume":"66","author":"Simpson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jcjo.2017.08.005_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2007.11.016","article-title":"Vitreous penetration of orally administered valacyclovir","volume":"145","author":"Huynh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.08.005_bib38","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jac\/dkt064","article-title":"Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model","volume":"68","author":"Schenkel","year":"2013","journal-title":"J Antimicrob Chemother"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418217304994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418217304994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:06:45Z","timestamp":1757794005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418217304994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0008418217304994"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.08.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of herpes zoster ophthalmicus: a systematic review and Canadian cost-comparison","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}